Pulmonary stenosis occurs when there is narrowing of the pulmonary valve or the area just above or below it.
Pulmonary stenosis refers to narrowing around the area of the pulmonary valve, which leads to restriction of blood flow from the right ventricle of the heart to the pulmonary artery.
Typically, pulmonary stenosis may be:
It is vital to differentiate severe and critical cogenital pulmonary stenosis from mild-to-moderate. This is because severe and critical congenital pulmonary stenosis is an acute onset, life-threatening condition which usually presents in the neonatal period. Due to the quite marked differences in presentation, investigation, and management, we will discuss severe and critical cogenital separately to mild-to-moderate congenital and adult-onset.
Approximately 95% of cases of pulmonary stenosis are congenital.
Pulmonary stenosis is primarily a paediatric condition, since 95% of cases are congenital. It occurs in ~1 in 1500 live births.
The cause of pulmonary stenosis may be congenital or acquired.
These account for approximately 95% of cases:
These account for approximately 5% of cases:
* Carcinoid syndrome involves the release of vasoactive substances from a tumour (usually of the gastrointestinal tract). It is possible that serotonin release from such a tumour leads to fibrous changes of the pulmonary valve, leading to regurgitation, stenosis, or both).
Most patients with mild-to-moderate congenital pulmonary stenosis or adult-onset will remain asymptomatic.
Most patients with mild-to-moderate congenital pulmonary stenosis or adult-onset will remain asymptomatic. For example, one study found that 96% of patients required no interventions for their PS after a 10 year follow up. However, in severe and critical pulmonary stenosis, the presentation is usually acute, life-threatening, and in the early neonatal period.
Here, we will discuss both presentations of pulmonary stenosis separately.
The majority of patients with pulmonary stenosis are born with a tricuspid valve. In other words, a valve with the normal number of leaflets. However, the leaflets are more fibrosed, thickened or fused.
Understanding the anatomy of pulmonary stenosis will help you understand the clinical features and treatment. In severe and critical PS, outflow from the right ventricle into the pulmonary artery is severely impaired. In the absence of an atrial septal defect or ventricular septal defect, there are only two ways blood can move from the right side of the heart to the left; via the foramen ovale or a patent ductus arteriosus.
Initially, infants and children with mild and moderate PS are asymptomatic. Most patients will remain asymptomatic. For example, one study found that 96% of patients required no interventions for their PS after a 10 year follow up.
In a minority of patients, the pulmonary valve undergoes gradual fibrous thickening (+/- calcification). As this fibrosis progresses, the valve becomes stiffer, meaning the degree of pulmonary stenosis becomes more severe.
This results in 3 issues:
Severe and critical congenital pulmonary stenosis usually presents in the early neonatal period.
The presentation of pulmonary stenosis in the neonatal period is mainly explained by the right-to-left shunt through the foramen ovale.
This allows deoxygenated blood to enter the systemic circulation, leading to:
Due to the cyanosis, this is considered a medical emergency. Resuscitation is appropriate either before – or in parallel to – diagnostic workup. Neonatal resuscitation is beyond the scope of this topic, but generally follows an ABCDE approach.
The key part of the acute management in severe and critical pulmonary stenosis is starting prostaglandins:
The typical features on history include:
Note that mild pulmonary stenosis causes no symptoms. If a patient with mild pulmonary stenosis presents with symptoms of right-heart failure, you should look for other causes for their symptoms.
On examination, typical findings of pulmonary stenosis include:
Echocardiography is the main diagnostic tool.
Echocardiography is the main diagnostic tool for pulmonary stenosis; it can both diagnose and grade pulmonary stenosis (see ‘Classification’ below). This is for both neonates with critical pulmonary stenosis and in mild-to-moderate or adult-onset cases.
Patients may undergo other tests during their workup, such as chest x-ray and ECG. The following results on these tests might point towards PS:
Grading pulmonary stenosis is based on the echocardiography.
On echocardiography, the estimated pressure gradient across the pulmonary valve is used to determine the grade. This differentiates the severity of pulmonary stenosis into mild, moderate, or severe.
NOTE: Different guidelines use different cut-off values for each category, but most sources quote values close to these.
Neonates with severe or critical PS require urgent intervention.
Any neonate with suspected severe or critical pulmonary stenosis requires urgent resuscitation, which should included starting a prostaglandin infusion to maintain a patent ductus arteriosus.
Once stable, patients will undergo surgical intervention.
The exact type of surgery depends on the morphology of each patient’s pulmonary stenosis:
The long-term prognosis for patients who undergo both balloon pulmonary valvuloplasty and surgical valvotomy is excellent.
The management depends on the severity of stenosis and whether patients are symptomatic or asymptomatic.
Patients with mild pulmonary stenosis may never require intervention, and have a normal life expectancy. Patients who undergo balloon valvotomy tend to do well. After reopening the valve, the pressure across it reduces over several months. With more time (i.e. months to years) right ventricular hypertrophy may start to reverse.
Have comments about these notes? Leave us feedback